Centeon buying albumin from other sources to fill Albuminar contracts during recall period.
Executive Summary
CENTEON BUYING ALBUMIN FROM OTHER SOURCES TO FILL CONTRACTS until shipments of Centeon's human albumin product Albuminar resume following the company's recall of all lots. "About half of Albuminar sales are to contract customers," Rhone-Poulenc Rorer VP-Investor Relations Arvind Sood told an Oppenheimer & Co. health care conference in New York City Oct. 28. Centeon is a joint venture of RPR and Hoechst. "Centeon is currently buying competitors' products on the spot market to make sure that...we are able to satisfy many of these contractual agreements and to retain customer loyalty," Sood continued.